AzTrials
AzTrials

Fluid Resuscitation Monitoring Non-invasivelyNCT04018443

The Relation Between Common Carotid Artery Diameter and Central Venous Pressure for Assessment of Intravascular Fluid Status After Major Surgeries: An Observational Study

An observational study of Fluid Resuscitation Monitoring Non-invasively, run by Beni-Suef University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Recently, bedside ultrasound has become an important tool for the simple and non-invasive hemodynamic assessment of critically ill patients. This applies not only to echocardiography but also to ultrasound of large extra-thoracic veins. Read more about this study

Who is it for?
Ages 20 to 60 years
What is being tested?
common carotid artery diameter measurement
Type of treatment
Injection or infusion
How many people
60 participants
Where
1 siteEgypt
Study dates
7 Apr 2019to 7 Oct 2019
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: patients scheduled for elective or emergency major surgeries including, including (but not limited to) (abdominal exploration for intestinal obstruction or after trauma, aorto-femoral bypass, radical cystectomy, etc..) that require post-operative close monitoring, assessment and resuscitation of the intravascular volume status

Who may be able to join

  • Male and female patients (age 20-60 years).
  • ASA physical status I and II
  • Patients who are able to breathe spontaneously and lie supine.
  • Patients who have CVP catheter (subclavian or internal jugular vein).

Who cannot join

  • History of carotid artery surgery
  • Significant cardiac disease (cardiomyopathy and/or moderate to severe valvular heart lesion).
  • Significant hepatic disease (Child-Pugh score B or C ).
  • Renal failure.
  • Obesity: BMI ˃ 30 kg/m2
  • Need for mechanical ventilation.
  • Pregnancy.
  • Unstable vital signs during the process of sonography (e.g. the patients on vasoactive drugs)

Trial locations and contacts

1 site in 1 country.

Samaa A. Kasem, MD contact

+201270159125

sama.a.kasem@gmail.com

Egypt1 site, 1 recruiting
  • Beni Suef

    Banī Suwayf, 62511

    Tarek Al Menesy, MD, +201141434355, tarek_gada@yahoo.com

    Ahmed A. BAdawy, MD

    Recruiting

Other trials in Egypt

About this study

Recently, bedside ultrasound has become an important tool for the simple and non-invasive hemodynamic assessment of critically ill patients. This applies not only to echocardiography but also to ultrasound of large extra-thoracic veins. The sonography can provide real time assessment of the vascular system and hemodynamic status at the bedside.

To our knowledge, there is one report about the association between sonographically assessed carotid artery diameter and intravascular volume, which raised recommendation for further studies including the interplay between carotid geometry and intravascular fluid status.

Read more

Aim of the study:

The aim of this work is to evaluate the accuracy of noninvasive techniques for assessment of intravascular volume status by Sonographic assessment of both the common carotid artery diameter (CCA) and the central venous pressure (CVP) in response to a bolus of crystalloid solution infusion and to find the correlation between CCA diameter and CVP as the primary outcome in adults patients after major surgeries who needs close assessment and maintenance of the intravascular volume status.

Being tested
common carotid artery diameter measurement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • common carotid artery diameter measurementDiagnostic test

    measurement of common carotid artery diameter will be carried out two times: the initial measurement (pre-infusion) which is followed by infusion of crystalloid solution (Ringer lactate) 30 ml/min till reaching a total infusion volume of 7 ml/kg body weight then another ultrasound measurement will be taken (prost-infusion). Between these sequential measurements, the patient position will not be changed. The percentage increase in CCA diameter will be calculated using the formula: [(dia-mpost/dia-mpre) × 100] - 100 [11].

Study groups in NCT04018443
Study groupRoleWhat they receive
patients admitted ti surgical ICU after major surgerypatient admitted to surgical ICU after major surgery for post-operative close monitoring, assessment and resuscitation of the intravascular volume status
Receives: Diagnostic Test: common carotid artery diameter measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Common Carotid Artery diameter at expiration (millimetre)

    common carotid artery internal diameter changes songraphically measured to assess intravenous resuscitation

    Measured: 30 minutes before fluid bolus infusion

  2. Common Carotid Artery diameter at expiration (millimetre)

    common carotid artery internal diameter changes songraphically measured to assess intravenous resuscitation

    Measured: 5 minutesafter fluid bolus infusion

  3. Central venous pressure (centimetre water)

    Central venous pressure changes measured to assess intravenous resuscitation

    Measured: 5 minutes after fluid bolus infusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2019
  2. Study start7 Apr 2019
  3. Primary completion7 Oct 2019 (estimated)
  4. Study completion7 Oct 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
60 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT04018443
Sponsor's protocol ID
FM-BSU REC: 007/2019
Status last verified
Jul 2019
First submitted
7 Jul 2019
Last updated
12 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Fluid Resuscitation Monitoring Non-invasively, run by Beni-Suef University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Samaa A. Kasem, MD (+201270159125, sama.a.kasem@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Common Carotid Artery diameter at expiration (millimetre) (time frame: 30 minutes before fluid bolus infusion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in